Aptamer-based targeted delivery of functional nucleic acids

S Xie, W Sun, T Fu, X Liu, P Chen, L Qiu… - Journal of the …, 2023 - ACS Publications
Functional nucleic acid (NA)-based drugs have a broad range of applications since they
allow the alteration and control of gene/protein expression patterns in cells. In principle …

Bone-targeted nanoparticle drug delivery system: an emerging strategy for bone-related disease

Y Chen, X Wu, J Li, Y Jiang, K Xu, J Su - Frontiers in Pharmacology, 2022 - frontiersin.org
Targeted delivery by either systemic or local targeting of therapeutics to the bone is an
attractive treatment for various bone metabolism diseases such as osteoporosis …

Aptamers: problems, solutions and prospects

AV Lakhin, VZ Tarantul, LV Gening - Acta Naturae (англоязычная …, 2013 - cyberleninka.ru
Aptamers are short single-stranded oligonucleotides that are capable of binding various
molecules with high affinity and specificity. When the technology of aptamer selection was …

SELEX methods on the road to protein targeting with nucleic acid aptamers

P Bayat, R Nosrati, M Alibolandi, H Rafatpanah… - Biochimie, 2018 - Elsevier
Systematic evolution of ligand by exponential enrichment (SELEX) is an efficient method
used to isolate high-affinity single stranded oligonucleotides from a large random sequence …

Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy

C Liang, B Guo, H Wu, N Shao, D Li, J Liu, L Dang… - Nature medicine, 2015 - nature.com
Currently, major concerns about the safety and efficacy of RNA interference (RNAi)-based
bone anabolic strategies still exist because of the lack of direct osteoblast-specific delivery …

[HTML][HTML] Selection and identification of a novel ssDNA aptamer targeting human skeletal muscle

S Sun, H Liu, Y Hu, Y Wang, M Zhao, Y Yuan, Y Han… - Bioactive Materials, 2023 - Elsevier
Skeletal muscle disorders have posed great threats to health. Selective delivery of drugs
and oligonucleotides to skeletal muscle is challenging. Aptamers can improve targeting …

Nucleic acid aptamers in cancer research, diagnosis and therapy

H Ma, J Liu, MM Ali, MAI Mahmood… - Chemical Society …, 2015 - pubs.rsc.org
Aptamers are single-stranded DNA or RNA oligomers, identified from a random sequence
pool, with the ability to form unique and versatile tertiary structures that bind to cognate …

Nanoparticles and DNA–a powerful and growing functional combination in bionanotechnology

A Samanta, IL Medintz - Nanoscale, 2016 - pubs.rsc.org
Functionally integrating DNA and other nucleic acids with nanoparticles in all their different
physicochemical forms has produced a rich variety of composite nanomaterials which, in …

Elucidation and structural modeling of CD71 as a molecular target for cell-specific aptamer binding

X Wu, H Liu, D Han, B Peng, H Zhang… - Journal of the …, 2019 - ACS Publications
Pancreatic cancer is a highly lethal malignancy associated with tissues of the pancreas.
Early diagnosis and effective treatment are crucial to improving the survival rate of patients …

Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin

L Zhang, L Li, X Wang, H Liu, Y Zhang, T Xie… - … Therapy-Nucleic Acids, 2022 - cell.com
PROteolysis TArgeting Chimeras (PROTACs) induce targeted protein degradation by
hijacking the intracellular ubiquitin proteasome system, thus emerging as a new strategy for …